Northeast, NY30+ days ago
enGene (NASDAQ: ENGN) is a late-stage biotechnology company, mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. $190,000 - $215,000 a year Location: USA - Field Based - Great Lakes Geography - inclusive of the following states: WI, MI, IA, MO, IL, IN, OH, KY, WV Candidates must live within this geography to be considered Salary: The salary range for this role is $190,000 to $215,000 The base salary range provided represents a good faith estimate of the compensation for this position at the time of posting.